VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,445 | -19.1% | 3,201 | +14.4% | 0.00% | -33.3% |
| Q2 2023 | $52,463 | +30.0% | 2,798 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $40,347 | -25.5% | 2,798 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $54,141 | -43.7% | 2,798 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $96,111 | +156.4% | 2,798 | +14.1% | 0.01% | +150.0% |
| Q2 2022 | $37,482 | -33.0% | 2,453 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $55,977 | -65.5% | 2,453 | -44.2% | 0.00% | 0.0% |
| Q4 2021 | $162,191 | -21.6% | 4,399 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $206,753 | – | 4,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,508,809 | $57,251,000 | 8.18% |
| Alphabet Inc. | 10,974,011 | $250,427,000 | 8.12% |
| M28 Capital Management LP | 178,500 | $4,073,000 | 3.74% |
| Casdin Capital, LLC | 3,138,167 | $71,613,000 | 3.21% |
| Ally Bridge Group (NY) LLC | 105,360 | $2,404,000 | 1.78% |
| Redmile Group, LLC | 1,835,328 | $41,882,000 | 1.31% |
| Cormorant Asset Management, LP | 700,710 | $15,990,000 | 1.23% |
| Novo Holdings A/S | 750,000 | $17,115,000 | 0.90% |
| Artal Group S.A. | 400,000 | $9,128,000 | 0.38% |
| PFM Health Sciences, LP | 369,765 | $8,438,000 | 0.32% |